Search - tctmd.com

Displaying 161 - 180 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

Portico: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar

November 01, 2016

Presentation TCT 2016

A Critical Review of Technique Across the Absorb Trials

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman

November 01, 2016

Presentation TCT 2016

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Presentation TCT 2016

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Jeffrey J. Popma

November 01, 2016

Presentation TCT 2016

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Christoph K. Naber

November 01, 2016

Presentation TCT 2016

Catheter-directed Interventions For Acute Pulmonary Emboli: Pigtails, Ekos, Angiojet, and Angiovac- Description, Data, and Cases

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Lindsay S. Machan

November 01, 2016

Presentation TCT 2016

FDA Perspectives on Short DAPT IDE Trials

Presenter: Michael C. John, Gregg W. Stone, Andrew Farb

November 01, 2016

Presentation TCT 2016

BRS Benchtop Findings: Implications for Implantation Techniques

Presenter: Stephen G. Ellis, Patrick W. Serruys, Nicolas Foin

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Presenter: Michael C. John, Gregg W. Stone, P.F. Adrian Magee

November 01, 2016

Advertisement

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Portico: Design Features, Special Attributes, and Clinical Trial Program

A Critical Review of Technique Across the Absorb Trials

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Catheter-directed Interventions For Acute Pulmonary Emboli: Pigtails, Ekos, Angiojet, and Angiovac- Description, Data, and Cases

FDA Perspectives on Short DAPT IDE Trials

BRS Benchtop Findings: Implications for Implantation Techniques

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content